piwik-script

Intern
Lehrstuhl für klinische Epidemiologie und Biometrie

Prof. Dr. Jens-Peter Reese

Prof. Dr. Jens-Peter Reese

Professor für Versorgungsforschung und Public Health
Petrinistr. 33a

kurzer Lebenslauf

seit 2020

Professor für Versorgungsforschung und Public Health am Institut für Klinische Epidemiologie und Biometrie, Universität Würzburg
2020 Außerplanmäßige Professur, FB Medizin, Philipps-Universität Marburg

2016-2020

Stellv. Leitung, Koordinierungszentrum für Klinische Studien, Philipps-Universität Marburg

2014-2016

Vertretung der Professur „Epidemiologie und Versorgungsforschung“ sowie kommissarische Leitung des Instituts für Medizinische Soziologie und Sozialmedizin Fachbereich Medizin der Philipps-Universität Marburg

2013

Habilitation für Medizinische Soziologie/ Klin. Versorgungsforschung, Philipps-Universität Marburg

2001-2014

Wissenschaftlicher Mitarbeiter Neurologie, Med. Soziologie, Philipps-Universität Marburg
2008 Dr. rer. nat.,  Philipps-Universität Marburg
2006 Master of Public Health, Universität Bielefeld
1995-2000 Studium der Biologie, Philipps-Universität Marburg & Universität Regensburg

 

wissenschaftliche Schwerpunkte

Evidence-based Public Health, Versorgungsepidemiologie und Gesundheitsökonomische Evaluation, komplexe Interventionen, Sekundärdatenanalyse, Evaluation innovativer Versorgungsformen

Publikationen

2024[ to top ]
  • 1.
    Lange B, Jaeger VK, Harries M, Rücker V, Streeck H, Blaschke S, et al. Estimates of protection levels against SARS-CoV-2 infection and severe COVID-19 in Germany before the 2022/2023 winter season: the IMMUNEBRIDGE project. Infection. 2024;52(1):139-53.
2023[ to top ]
  • 1.
    Heyder R, Kroemer HK, Wiedmann S, Pley C, Heyer C, Heuschmann P, et al. Das Netzwerk Universitätsmedizin: Technisch-organisatorische Ansätze für Forschungsdatenplattformen. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz [Internet]. 2023;66(2):114-25. Available from: https://doi.org/10.1007/s00103-022-03649-1
  • 1.
    Shi Y, Strobl R, Apfelbacher C, Bahmer T, Geisler R, Heuschmann P, et al. Persistent symptoms and risk factors predicting prolonged time to symptom-free after SARS‑CoV‑2 infection: an analysis of the baseline examination of the German COVIDOM/NAPKON-POP cohort. Infection. 2023;:1-16.
  • 1.
    Lange B, Jaeger VK, Harries M, Rücker V, Streeck H, Blaschke S, et al. Estimates of protection levels against SARS-CoV-2 infection and severe COVID-19 in Germany before the 2022/2023 winter season: the IMMUNEBRIDGE project. Infection. 2023;.
  • 1.
    Yusuf KO, Miljukov O, Schoneberg A, Hanß S, Wiesenfeldt M, Stecher M, et al. Consistency as a Data Quality Measure for German Corona Consensus Items Mapped from National Pandemic Cohort Network Data Collections. Methods Inf Med. 2023;62(S 01):e47-e56.
  • 1.
    Tilch K, Hopff SM, Appel K, Kraus M, Lorenz-Depiereux B, Pilgram L, et al. Ethical and coordinative challenges in setting up a national cohort study during the COVID-19 pandemic in Germany. BMC Med Ethics. 2023;24(1):84.
  • 1.
    Engels G, Oechsle AL, Schlegtendal A, Maier C, Holzwarth S, Streng A, et al. SARS-CoV-2 sero-immunity and quality of life in children and adolescents in relation to infections and vaccinations: the IMMUNEBRIDGE KIDS cross-sectional study, 2022. Infection. 2023;51(5):1531-9.
  • 1.
    Yusuf KO, Chaplinskaya-Sobol I, Schoneberg A, Hanss S, Valentin H, Lorenz-Depiereux B, et al. Impact of Clinical Study Implementation on Data Quality Assessments - Using Contradictions within Interdependent Health Data Items as a Pilot Indicator. Stud Health Technol Inform. 2023;307:152-8.
2022[ to top ]
  • 1.
    Willems LM, Hochbaum M, Frey K, Schulz J, Menzler K, Langenbruch L, et al. Multicenter, cross-sectional study of the costs of illness and cost-driving factors in adult patients with epilepsy. Epilepsia [Internet]. 2022;63(4):904-18. Available from: https://doi.org/10.1111/epi.17174
  • 1.
    Lange B, Jäger VK, Rücker V, Harries M, Hassenstein MJ, Dreier M, et al. 2. Interimsanalyse des IMMUNEBRIDGE-Projektes zur Kommunikation von vorläufigen Ergebnissen an das Modellierungsnetz für schwere Infektionskrankheiten. Zenodo. 2022;.
  • 1.
    Willems LM, Knake S, Rosenow F, Reese JP, Conradi N, Strzelczyk A. EuroQOL-5D-3L does not adequately map quality-of-life deterioration in severely affected patients with epilepsy. Epilepsy & Behavior [Internet]. 2022;127:108554. Available from: https://www.sciencedirect.com/science/article/pii/S1525505022000038
  • 1.
    Willems LM, Hochbaum M, Zöllner JP, Schulz J, Menzler K, Langenbruch L, et al. Trends in resource utilization and cost of illness in patients with active epilepsy in Germany from 2003 to 2020. Epilepsia [Internet]. 2022;63(6):1591-602. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1111/epi.17229
  • 1.
    Lange B, Jäger V, Rücker V, Hassenstein M, Harries M, Berner R, et al. Interimsanalyse des IMMUNEBRIDGE-Projektes zur Kommunikation von vorläufigen Ergebnissen an die Modellierungskonsortien der BMBF-geförderten Modellierungsplattform. Zenodo. 2022;.
  • 1.
    Schons M, Pilgram L, Reese JP, Stecher M, Anton G, Appel KS, et al. The German National Pandemic Cohort Network (NAPKON): rationale, study design and baseline characteristics. Eur J Epidemiol. 2022;37(8):849-70.
  • 1.
    Bahmer T, Borzikowsky C, Lieb W, Horn A, Krist L, Fricke J, et al. Severity, predictors and clinical correlates of Post-COVID syndrome (PCS) in Germany: A prospective, multi-centre, population-based cohort study. EClinicalMedicine. 2022;51:101549.
  • 1.
    Koll CEM, Hopff SM, Meurers T, Lee CH, Kohls M, Stellbrink C, et al. Statistical biases due to anonymization evaluated in an open clinical dataset from COVID-19 patients. Sci Data. 2022;9(1):776.
  • 1.
    Kananian S, Kip A, Schumm H, Giesebrecht J, Nicolai A, Schade-Brittinger C, et al. Culturally adapted cognitive behavioural group therapy for mental disorders in refugees plus problem solving training (ReTreat): study protocol for a multicentre randomised controlled trial. BMJ Open. 2022;12(11):e061274.
  • 1.
    Appel KS, Maier D, Hopff SM, Mitrov L, Stecher M, Scherer M, et al. 1886. External Validation of the 4C Mortality Score and the qSOFA for Different Variants of Concerns of SARS-CoV-2 Using Data of the NAPKON Cross-Sectoral Cohort Platform (SUEP). Open Forum Infectious Diseases [Internet]. 2022;9(Supplement_2). Available from: https://doi.org/10.1093/ofid/ofac492.1513
  • 1.
    Krause D, Mai A, Denz R, Johow J, Reese JP, Westerhoff B, et al. The Structured Delegation of Medical Care Services for Patients With Inflammatory Rheumatic Diseases. Dtsch Arztebl Int. 2022;119(10):157-64.
2021[ to top ]
  • 1.
    Horn A, Krist L, Lieb W, Montellano FA, Kohls M, Haas K, et al. Long-term health sequelae and quality of life at least 6 months after infection with SARS-CoV-2: design and rationale of the COVIDOM-study as part of the NAPKON population-based cohort platform (POP). Infection. 2021;49(6):1277-8.
  • 1.
    Reese J. Prescription of Memantine/Donepezil. Neurology: Clinical Practice [Internet]. 2021;11(3):179. Available from: http://cp.neurology.org/content/11/3/179.abstract
  • 1.
    Weise C, Grupp F, Reese JP, Schade-Brittinger C, Ehring T, Morina N, et al. Efficacy of a Low-threshold, Culturally-Sensitive Group Psychoeducation Programme for Asylum Seekers (LoPe): study protocol for a multicentre randomised controlled trial. BMJ Open. 2021;11(10):e047385.
  • 1.
    Steil R, Lechner-Meichsner F, Johow J, Krüger A, Mewes R, Reese JP, et al. Brief imagery rescripting vs. usual care and treatment advice in refugees with posttraumatic stress disorder: study protocol for a multi-center randomized-controlled trial. European Journal of Psychotraumatology. 2021;12:1872967.
  • 1.
    Zöllner JP, Conradi N, Sauter M, Knuf M, Knake S, Kurlemann G, et al. Quality of life and its predictors in adults with tuberous sclerosis complex (TSC): a multicentre cohort study from Germany. Neurol Res Pract. 2021;3(1):35.